Loading the company…
Loading the company…
㈜트레바이오
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2008. Industry: Wholesale & Retail. Revenue for 2025 was ₩82.2bn. It has 7 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2024-11-28 · latest registration 2026-02-05 · newest first
본 발명은 돼지의 생산성 향상을 위한 사료 기호성 증진용 사료첨가제 조성물에 관한 것으로, 보다 상세하게는 마늘(Allium sativum) 분말, 오레가노(Origanum vulgare) 분말 및 팔각(Illicium verum) 분말을 유효성분으로 함유하는 돼지의 생산성 향상을 위한 사료 기호성 증진용 사료첨가제 조성물에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 74.2 | 82.2 |
| Cost of sales | 69.3 | 77.6 |
| Gross profit (loss) | 4.9 | 4.6 |
| Selling, general and administrative expenses | 2.4 | 3.0 |
| Operating income (loss) | 2.5 | 1.6 |
| Non-operating income | 0.9 | 1.7 |
| Other gains | 0.4 | 0.0 |
| Finance income | 0.1 | 0.1 |
| Other | 0.4 | 1.6 |
| Non-operating expenses | 3.3 | 2.7 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 1.3 | 1.1 |
| Other | 2.0 | 1.6 |
| Profit (loss) before tax | 0.1 | 0.5 |
| Income tax expense | 0.0 | — |
| Net income (loss) | 0.1 | 0.5 |
Revenue ₩82.2bn, up 10.8% YoY.
Operating margin 1.9% (prior 3.4%).
Net income ₩0.5bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05